 MINNEAPOLIS, MN ACCESSWIRE November 22, 2022 Celcuity Inc. NASDAQ:CELC, a clinical-stage biotechnology company focused on development of targeted therapies for cancer treatment, today announced that an abstract accepted for a Spotlight Poster presentation at the 2022 San Antonio Breast Cancer Symposium SABCS is now available on the SABCS website. The 2022 San Antonio Breast Cancer Symposium SABCS is being held virtually and in-person from December 6-10, 2022. 